Exploring the Intersection between Childhood Cancer and Birth Defects to Identify Novel Cancer Predisposition Syndromes |
Baylor College of Medicine / Philip Lupo, PhD |
Epidemiology Grants |
2014 |
Texas |
Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2 |
Baylor College of Medicine / Andras Heczey, MD |
Young Investigator Grants |
2014 |
Texas |
Optimizing Engager T-cells for CD19+ Malignancies |
Baylor College of Medicine / Mireya Paulina Velasquez, MD |
Young Investigator Grants |
2014 |
Texas |
STAT3 Signaling Profiles Predict Response to Chemotherapy in Pediatric AML |
Baylor College of Medicine / Michele Redell, M.D./Ph.D. |
Springboard Grants |
2014 |
Texas |
Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer |
Baylor College of Medicine / Stephen Gottschalk, M.D. |
Innovation Grants |
2014 |
Texas |
Immunotherapy of Neuroblastoma with CAR.GD2 NKT Cells |
Baylor College of Medicine / Leonid S. Metelitsa, M.D., Ph.D. |
Bio-Therapeutic Impact Award |
2014 |
Texas |
Elucidating the Mechanism of ERK Mediated Pathogenesis of LCH |
Baylor College of Medicine / Rikhia Chakraborty, PhD |
Young Investigator Grants |
2015 |
Texas |
Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene |
Baylor College of Medicine / Robin Parihar, MD, PhD |
Young Investigator Grants |
2015 |
Texas |
Genetically Engineered T Cells as Therapy for Pediatric Glioma |
Baylor College of Medicine / Giedre Krenciute, PhD |
Young Investigator Grants |
2016 |
Texas |
Interrogating the Enhancer Landscapes of Ependymoma to Inform Novel Therapies |
Baylor College of Medicine / Stephen Mack, PhD |
Young Investigator Grants |
2016 |
Texas |